Phathom Pharmaceuticals, Inc. PHAT NJ — Lessee Operating Lease Number Of Option To Extend
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept phat:LesseeOperatingLeaseNumberOfOptionToExtend.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s nj — lessee operating lease number of option to extend.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s NJ — lessee operating lease number of option to extend?
- Phathom Pharmaceuticals, Inc. (PHAT) reported NJ — lessee operating lease number of option to extend of 1 in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s NJ — lessee operating lease number of option to extend changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s NJ — lessee operating lease number of option to extend decreased by 0.0% year-over-year, from 1 to 1.
- What does NJ — lessee operating lease number of option to extend mean?
- This metric represents the total count of contractual options available to the company to extend the lease term for operating assets within the specified geographic or operational segment. It provides insight into the company's flexibility to maintain its physical footprint and operational continuity in a specific region. Monitoring this count helps investors assess potential future lease commitments and the strategic optionality regarding facility usage.